Tradestie Institutional Equity Comparison Engine

AMS vs LH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

LH Overall Edge

LH Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Labcorp Holdings Inc. (LH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AMS trades at 44.6x Forward P/E with -7.4% operating margin (+19.2% YoY revenue) versus LH at 19.0x Forward P/E and 11.2% operating margin (+6.9% YoY). In options structure, AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LH sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner LH
AMS 44.6x vs LH 19.0x Fwd P/E
Growth & Margin Winner LH
Op Margin -7.4% vs 11.2% ยท YoY +19.2% vs +6.9%
Momentum & Technical Winner LH
1Y -52.2% vs +39.0% ยท 52W Pos 6% vs 98%
Options & Structure Winner LH
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (16th %ile IV)
AMS NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap $7.2M
1M Return -16.41%
1Y Return -52.23%
Forward P/E 44.6x
Unified AI Score
33.8 / 100 SELL
Tech 24.0 Fund 38.0 Flow 50.0 Mom 30.0
LH NYSE
Labcorp Holdings Inc.
Services-Medical Laboratories
$372.46
+0.53% 1D
Market Cap $30.1B
1M Return +17.14%
1Y Return +39.05%
Forward P/E 19.0x
Unified AI Score
40.8 / 100 SELL
Tech 17.0 Fund 35.0 Flow 58.0 Mom 31.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMS -52.23% LH +39.05% Spread: +91.28 pp (LH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AMS Revenue LH Revenue AMS Op. Margin LH Op. Margin Margin Edge
FY2018 $20M $11.3B 9.4% 11.7% LH
FY2019 $20M $11.6B 7.5% 11.5% LH
FY2020 $20M $14.0B -53.1% 17.5% LH
FY2021 $20M $13.1B 7.7% 23.2% LH
FY2022 $20M $11.9B 12.3% 12.1% AMS
FY2023 $20M $12.2B 1.3% 6.0% LH
FY2024 $30M $13.0B -9.9% 8.4% LH
FY2025 $30M $13.9B -12.8% 9.9% LH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMS (1) vs LH (9)
Institutional Metric AMS LH Criterion Row Winner
Market Capitalization Scale $7.2M $30.1B Larger Scale LH
Trailing P/E Ratio Valuation 44.6x 30.4x Lower Multiple LH
Forward P/E Ratio Valuation 44.6x 19.0x Lower Multiple LH
Revenue Growth (YoY) Growth +19.2% +6.9% Higher Growth AMS
Operating Margin (TTM) Profitability -7.4% 11.2% Higher Margin LH
Net Profit Margin Profitability -5.8% 6.9% Higher Margin LH
Return on Equity (ROE) Capital Efficiency -12.1% 11.4% Higher ROE LH
52-Week Range Position Momentum 6% ($1โ€“$2) 98% ($245โ€“$375) Stronger Trend LH
Beta / 30D Volatility Risk Regime 0.18ฮฒ ยท 46% Vol 0.37ฮฒ ยท 36% Vol Lower Realized Risk LH
Unified Institutional Score Composite Signal 33.8 / 100 (SELL) 40.8 / 100 (SELL) Higher Composite LH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMS vs LH Buy Guide
AMS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AMS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LH CONSOLIDATION
59d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live LH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMS nor LH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.